Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ensysce Biosciences Inc (NQ: ENSC )

0.5341 +0.0008 (+0.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 10, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 662,105
Open 0.4645
Bid (Size) 0.5111 (110)
Ask (Size) 0.5290 (1)
Prev. Close 0.5333
Today's Range 0.4600 - 0.5341
52wk Range 0.3932 - 7.000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
  
Via Benzinga

Performance

YTD
-87.55%
-87.55%
1 Month
-12.80%
-12.80%
3 Month
-16.55%
-16.55%
6 Month
-68.95%
-68.95%
1 Year
-85.94%
-85.94%

More News

Read More
Ensysce Biosciences Announces Completion of $8 Million Convertible Note Financing
Via ACCESSWIRE
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Ensysce Biosciences Announces Positive Bioequivalence (BE) Study Data of Novel "TAAP" Opioid PF614 and Provides Timing of Corporate Update Call
Via ACCESSWIRE
Ensysce Biosciences Announces Positive Bioequivalence (BE) Study Data of Novel "TAAP" Opioid PF614 and Provides Timing of Corporate Update Call
From Ensysce Biosciences, Inc.
Via AccessWire
Exposures Product Safety
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Ensysce Biosciences Announces Initial Patients Dosed of First Human Abuse Potential Study
From Ensysce Biosciences, Inc.
Via AccessWire
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
Via Benzinga
Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Is Akebia Therapeutics (AKBA) Stock Up 14% Today?
Via InvestorPlace
Why Is Ensyce Biosciences (ENSC) Stock Down 27% Today?
Via InvestorPlace
Ensysce Biosciences Secures $8 Million Convertible Note Financing
From Ensysce Biosciences, Inc.
Via AccessWire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Akebia Therapeutics And 20 Stocks Moving Premarket
Via Benzinga
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
Via Benzinga
Ensysce Biosciences Receives Notice of Award for 4th Year of Funding for Its Multi-Pill Abuse Resistance (MPAR(TM)) Platform
From Ensysce Biosciences, Inc.
Via AccessWire
Ensysce Biosciences Reminds Shareholders to Vote At Upcoming 2022 Virtual Annual Shareholder Meeting
From Ensysce Biosciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Exposures Death Intellectual Property
The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures
Via Benzinga
Ensysce Biosciences Announces Initiation of First Human Abuse Potential Study
From Ensysce Biosciences, Inc.
Via AccessWire
Ensysce Biosciences Provides Business Update and Reports First Quarter 2022 Financial Results
From Ensysce Biosciences, Inc.
Via AccessWire
Ensysce Biosciences Releases 2021 Annual Shareholder Letter
From Ensysce Biosciences, Inc.
Via AccessWire
Topics Death Intellectual Property Regulatory Compliance
Exposures Death Intellectual Property Legal
Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030
Via FinancialNewsMedia
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.